Trials / Completed
CompletedNCT01325571
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the Efficacy and Safety of Tacrolimus Capsule in Myasthenia Gravis That Was Insufficiently Treated by Glucocorticoid Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of tacrolimus capsules in patients with myasthenia gravis who are inadequately treated by glucocorticoid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus capsule | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2011-03-30
- Last updated
- 2016-03-09
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01325571. Inclusion in this directory is not an endorsement.